When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Tocilizumab - Wikipedia

   en.wikipedia.org/wiki/Tocilizumab

   Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).

3. Medication package insert - Wikipedia

   en.wikipedia.org/wiki/Medication_package_insert

   The Prescribing Information follows one of two formats: "physician labeling rule" format or "old" (non-PLR) format. For "old" format labeling a "product title" may be listed first and may include the proprietary name (if any), the nonproprietary name, dosage form(s), and other information about the product.

4. FDA Approves Expanded Indication for ACTEMRA® in Rheumatoid ...

   www.aol.com/2012/10/12/fda-approves-expanded...

   FDA Approves Expanded Indication for ACTEMRA ® in Rheumatoid Arthritis SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY ...

5. Anti-interleukin-6 - Wikipedia

   en.wikipedia.org/wiki/Anti-interleukin-6

   The first approved medication in this class, tocilizumab (Actemra), is an antibody directed against the IL6-receptor. [8] The second, siltuximab (Sylvant), is directed against IL-6 itself. [ 1 ] [ 9 ] Siltuximab is approved for treatment of human immunodeficiency virus-negative and HHV-8 -negative patients with multicentric Castleman's disease .

6. FDA Approves ACTEMRA® for Children Living with a Rare ... - AOL

   www.aol.com/2013/04/30/fda-approves-actemra-for...

   FDA Approves ACTEMRA ® for Children Living with a Rare Form of Arthritis Medicine Offers a New Option for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (PJIA) SOUTH SAN FRANCISCO ...

7. TNF inhibitor - Wikipedia

   en.wikipedia.org/wiki/TNF_inhibitor

   A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response.TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriasis, hidradenitis suppurativa and refractory asthma, so TNF inhibitors may be used in their ...

8. World Economic Forum says Trump to take part virtually in ...

   www.aol.com/world-economic-forum-says-trump...

   U.S. President Donald Trump will take part virtually in the World Economic Forum's annual meeting in Davos just days after his inauguration, the forum president said Tuesday. Børge Brende, a ...

9. Genentech - Wikipedia

   en.wikipedia.org/wiki/Genentech

   2010: Actemra (tocilizumab): The first interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody approved to treat rheumatoid arthritis. 2011: Zelboraf (vemurafenib): For the treatment of metastatic melanoma caused by BRAF mutation. 2012: Erivedge (vismodegib): Treatment for advanced basal-cell carcinoma (BCC).